
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company – Represents Third Customer in the Country
February 8, 2023 PharmaCielo has received a purchase order for CBD Isolate as an API, which will be used by a large pharmaceutical company in Brazil (the “Customer”), for final testing. The Customer has already qualified PharmaCielo as a supplier of API – the Company